Israel Englander Soleno Therapeutics Inc Transaction History

Millennium Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.14 - $0.23 $6,484 - $10,653	46,318 New	46,318 $9,000
Q3 2021 Nov 15, 2021	SELL	$0.8 - $1.12 $155,972 - $218,360	-194,965 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$0.97 - $1.32 $189,116 - $257,353	194,965 New	194,965 $222,000
Q4 2020 Feb 16, 2021	SELL	$1.61 - $2.23 $98,390 - $136,279	-61,112 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.71 - $2.51 $34,369 - $50,448	20,099 Added 49.01%	61,112 $153,000
Q2 2020 Aug 14, 2020	SELL	$1.77 - $4.23 $166,739 - $398,478	-94,203 Reduced 69.67%	41,013 $91,000
Q1 2020 May 14, 2020	BUY	$1.64 - $3.85 $221,754 - $520,581	135,216 New	135,216 $322,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $375M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.